RC-3095 acetate is an antagonist of bombesin/gastrin-releasing peptide receptor (GRPR). It exerts protective effects by reducing gastric oxidative injury in the arthritic mice.

RC-3095 impairs aversive but not recognition memory in Wistar male rats [1]. RC-3095 (0.3 mg/kg or 1 mg/kg; S.C.) shows anti-inflammatory effects in 2 experimental models of arthritis, collagen-induced arthritis, and antigen-induced arthritis. Arthritic mice treated with RC-3095 show a significant reduction in the concentrations of IL-1, IL-17, and TNF, and showed a diminished expression of GRPR [2].

162666-31-1

C58H83N15O11

1166.37

RC-3095 acetate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years